Skip to Main Content

Paper Details

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
Cell
374
2020
ChAd, ChAd-SARS-CoV-2-S, IgA, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2-S, T cell, chimpanzee, coronavirus disease, human, human angiotensin-converting enzyme 2 receptor, immunoglobulin A, inflammation, lung infection, mice, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 2, spike protein, viral RNA
Author NameAffiliation
Rita E ChenWashington University School of Medicine
Laura A VanBlarganWashington University School of Medicine
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Michael J HoltzmanWashington University School of Medicine
Michael S DiamondWashington University School of Medicine, USA The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs
  • 1 - 9

Datasets

Release 1.2